<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39122965</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID science, research and policy.</ArticleTitle><Pagination><StartPage>2148</StartPage><EndPage>2164</EndPage><MedlinePgn>2148-2164</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-024-03173-6</ELocationID><Abstract><AbstractText>Long COVID represents the constellation of post-acute and long-term health effects caused by SARS-CoV-2 infection; it is a complex, multisystem disorder that can affect nearly every organ system and can be severely disabling. The cumulative global incidence of long COVID is around 400 million individuals, which is estimated to have an annual economic impact of approximately $1 trillion-equivalent to about 1% of the global economy. Several mechanistic pathways are implicated in long COVID, including viral persistence, immune dysregulation, mitochondrial dysfunction, complement dysregulation, endothelial inflammation and microbiome dysbiosis. Long COVID can have devastating impacts on individual lives and, due to its complexity and prevalence, it also has major ramifications for health systems and economies, even threatening progress toward achieving the Sustainable Development Goals. Addressing the challenge of long COVID requires an ambitious and coordinated-but so far absent-global research and policy response strategy. In this interdisciplinary review, we provide a synthesis of the state of scientific evidence on long COVID, assess the impacts of long COVID on human health, health systems, the economy and global health metrics, and provide a forward-looking research and policy roadmap.</AbstractText><CopyrightInformation>&#xa9; 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Aly</LastName><ForeName>Ziyad</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-2600-0434</Identifier><AffiliationInfo><Affiliation>VA St. Louis Health Care System, Saint Louis, MO, USA. zalaly@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Washington University in St. Louis, Saint Louis, MO, USA. zalaly@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1245-2034</Identifier><AffiliationInfo><Affiliation>Patient-led Research Collaborative, Calabasas, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCorkell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3261-6737</Identifier><AffiliationInfo><Affiliation>Patient-led Research Collaborative, Calabasas, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Let&#xed;cia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-led Research Collaborative, Calabasas, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wulf-Hanson</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7824-9856</Identifier><AffiliationInfo><Affiliation>Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Topol</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-1478-4729</Identifier><AffiliationInfo><Affiliation>Scripps Institute, San Diego, California, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>20</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>10</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39122965</ArticleId><ArticleId IdType="doi">10.1038/s41591-024-03173-6</ArticleId><ArticleId IdType="pii">10.1038/s41591-024-03173-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly, Z., Xie, Y. &amp; Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259&#x2013;264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z. &amp; Topol, E. Solving the puzzle of Long COVID. Science 383, 830&#x2013;832 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38386747</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. &amp; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583&#x2013;590 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35132265</ArticleId><ArticleId IdType="pmc">8938267</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406&#x2013;2415 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36138154</ArticleId><ArticleId IdType="pmc">9671811</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E. &amp; Al-Aly, Z. Risks of mental health outcomes in people with COVID-19: cohort study. Br. Med. J. 376, e068993 (2022).</Citation></Reference><Reference><Citation>Al-Aly, Z. &amp; Rosen, C. J. Long COVID and impaired cognition - more evidence and more work to do. N. Engl. J. Med. 390, 858&#x2013;860 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38416434</ArticleId><ArticleId IdType="pmc">11156184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S. et al. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat. Hum. Behav. https://doi.org/10.1038/s41562-024-01895-8 (2024).</Citation></Reference><Reference><Citation>Xie, Y. &amp; Al-Aly, Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 10, 311&#x2013;321 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35325624</ArticleId><ArticleId IdType="pmc">8937253</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study. Lancet Diabetes Endocrinol. 11, 120&#x2013;128 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36623520</ArticleId><ArticleId IdType="pmc">9873268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe, B., Xie, Y., Xu, E. &amp; Al-Aly, Z. Kidney outcomes in long COVID. J. Am. Soc. Nephrol. 32, 2851&#x2013;2862 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34470828</ArticleId><ArticleId IdType="pmc">8806085</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218&#x2013;225 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38212464</ArticleId><ArticleId IdType="pmc">10834368</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J., Abdel-Mohsen, M., Henrich, T. J. &amp; Roan, N. R. Systems analysis of innate and adaptive immunity in Long COVID. Semin. Immunol. 72, 101873 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38460395</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack, B. et al. Female reproductive health impacts of Long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: a literature review. Front. Rehabil. Sci. 4, 1122673 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37234076</ArticleId><ArticleId IdType="pmc">10208411</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Long-term gastrointestinal outcomes of COVID-19. Nat. Commun. 14, 983 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36882400</ArticleId><ArticleId IdType="pmc">9992516</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann, P., Pittet, L. F. &amp; Curtis, N. How common is Long COVID in children and adolescents? Pediatr. Infect. Dis. J. 40, e482&#x2013;e487 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34870392</ArticleId><ArticleId IdType="pmc">8575095</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, S. et al. Postacute sequelae of SARS-CoV-2 in children. Pediatrics 153, e2023062570 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38321938</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurdasani, D. et al. Long COVID in children. Lancet Child Adolesc. Health 6, e2 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34921807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell, V., Hall Dykgraaf, S., Kidd, M. &amp; Goodyear-Smith, F. Long COVID and older people. Lancet Healthy Longev. 3, e849&#x2013;e854 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung, K. W., Baye, F., Baik, S. H., Zheng, Z. &amp; McDonald, C. J. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med. 20, e1004194 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37068113</ArticleId><ArticleId IdType="pmc">10150975</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Bowe, B. &amp; Al-Aly, Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 12, 6571 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34772922</ArticleId><ArticleId IdType="pmc">8589966</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn, S. &amp; Whitelaw, S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol. Res. 69, 205&#x2013;211 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33786700</ArticleId><ArticleId IdType="pmc">8009458</ArticleId></ArticleIdList></Reference><Reference><Citation>Volberding, P. A., Chu, B. X. &amp; Spicer, C. M. Long-Term Health Effects of COVID-19 (The National Academies Press, 2024).</Citation></Reference><Reference><Citation>Choutka, J., Jansari, V., Hornig, M. &amp; Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med. 28, 911&#x2013;923 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik, S. &amp; Eaton-Fitch, N. Understanding myalgic encephalomyelitis. Science 377, 1150&#x2013;1151 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A. L. &amp; Lipkin, W. I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front. Med. 10, 1187163 (2023).</Citation></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Ziyad, A.-A. Postacute sequelae of SARS-CoV-2 infection in the pre-delta, delta, and omicron eras. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2403211 (2024).</Citation></Reference><Reference><Citation>Kuang, S. et al. Experiences of Canadians with long-term symptoms following COVID-19. Statistics Canada https://www150.statcan.gc.ca/n1/pub/75-006-x/2023001/article/00015-eng.htm (8 December 2023).</Citation></Reference><Reference><Citation>Bowe, B., Xie, Y. &amp; Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 28, 2398&#x2013;2405 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36357676</ArticleId><ArticleId IdType="pmc">9671810</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth, M. L. et al. Risk of new-onset long COVID following reinfection with severe acute respiratory syndrome coronavirus 2: a community-based cohort study. Open Forum Infect. Dis. 10, ofad493 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37953820</ArticleId><ArticleId IdType="pmc">10633780</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. J. Am. Med. Assoc. 328, 1604&#x2013;1615 (2022).</Citation></Reference><Reference><Citation>Graham, F. Daily briefing: answers emerge about long COVID recovery. Nature https://doi.org/10.1038/d41586-023-02190-8 (2023).</Citation></Reference><Reference><Citation>Mateu, L. et al. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg. Health Eur. 33, 100724 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37954002</ArticleId><ArticleId IdType="pmc">10636281</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Canales, L. G. et al. Persistence of COVID-19 symptoms and quality of life at three and twelve months after hospital discharge. Medicina 60, 944 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38929561</ArticleId><ArticleId IdType="pmc">11205838</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 398, 747&#x2013;758 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34454673</ArticleId><ArticleId IdType="pmc">8389999</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study. Lancet Respir. Med. 12, 55&#x2013;66 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38000376</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe, B., Xie, Y. &amp; Al-Aly, Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 29, 2347&#x2013;2357 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37605079</ArticleId><ArticleId IdType="pmc">10504070</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z. Diabetes after SARS-CoV-2 infection. Lancet Diabetes Endocrinol. 11, 11&#x2013;13 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36463908</ArticleId></ArticleIdList></Reference><Reference><Citation>Fineberg, H. V., Brown, L., Worku, T. &amp; Goldowitz, I. A Long COVID Definition (National Academies Press, 2024).</Citation></Reference><Reference><Citation>Taquet, M. et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1,284,437 patients. Lancet Psychiatry 9, 815&#x2013;827 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35987197</ArticleId><ArticleId IdType="pmc">9385200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, M., Xie, Y., Topol, E. J. &amp; Al-Aly, Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat. Med. 30, 1564&#x2013;1573 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38816608</ArticleId><ArticleId IdType="pmc">11186764</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34308300</ArticleId><ArticleId IdType="pmc">8280690</ArticleId></ArticleIdList></Reference><Reference><Citation>Re&#x2019;em, Y. et al. Factors associated with psychiatric outcomes and coping in Long COVID. Nat. Ment. Health 1, 361&#x2013;372 (2023).</Citation></Reference><Reference><Citation>Re&#x2019;em, Y., Symeonides, M. &amp; McCorkell, L. Serology test results and other important characteristics of patients with persistent COVID-19 symptoms. JAMA Intern. Med. 182, 576&#x2013;577 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35311913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen, N. et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS ONE 17, e0264331 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35259179</ArticleId><ArticleId IdType="pmc">8903286</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien, K. K. et al. Conceptualising the episodic nature of disability among adults living with Long COVID: a qualitative study. BMJ Glob. Health 8, e011276 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36863719</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn, S. &amp; Verduzco-Gutierrez, M. Long COVID: a major public health issue. Am. J. Phys. Med. Rehabil. https://doi.org/10.1097/PHM.0000000000002486 (2024).</Citation></Reference><Reference><Citation>Ledford, H. How common is long COVID? Why studies give different answers. Nature 606, 852&#x2013;853 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35725828</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow, M. et al. Systematic review of the prevalence of Long COVID. Open Forum Infect. Dis. 10, ofad233 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37404951</ArticleId><ArticleId IdType="pmc">10316694</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjaye-Gbewonyo, D., Vahratian, A., Perrine, C. G. &amp; Bertolli, J. Long COVID in adults: United States, 2022. NCHS Data Brief 480, 1&#x2013;8 (2023).</Citation></Reference><Reference><Citation>Vahratian, A., Adjaye-Gbewonyo, D., Lin, J. S. &amp; Saydah, S. Long COVID in children: United States, 2022. NCHS Data Brief 479, 1&#x2013;6 (2023).</Citation></Reference><Reference><Citation>Fang, Z., Ahrnsbrak, R. &amp; Rekito, A. Evidence mounts that about 7% of US adults have had long COVID. J. Am. Med. Assoc 332, 5&#x2013;6 (2024).</Citation></Reference><Reference><Citation>National Center for Health Statistics. Long COVID: Household Pulse Survey. CDC https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm (accessed 1 July 2024).</Citation></Reference><Reference><Citation>UK Office of National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023/ (30 March 2023).</Citation></Reference><Reference><Citation>COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet 399, 2351&#x2013;2380 (2022).</Citation></Reference><Reference><Citation>GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950&#x2013;2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet 403, 1989&#x2013;2056 (2024).</Citation></Reference><Reference><Citation>GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990&#x2013;2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2100&#x2013;2132 (2024).</Citation></Reference><Reference><Citation>GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990&#x2013;2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2133&#x2013;2161 (2024).</Citation></Reference><Reference><Citation>GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990&#x2013;2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2162&#x2013;2203 (2024).</Citation></Reference><Reference><Citation>Antonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S. &amp; Steves, C. J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 399, 2263&#x2013;2264 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35717982</ArticleId><ArticleId IdType="pmc">9212672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Y. et al. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health 20, 1613 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36674367</ArticleId><ArticleId IdType="pmc">9863678</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J. &amp; Boyton, R. J. The immunology of long COVID. Nat. Rev. Immunol. 23, 618&#x2013;634 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A. D. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat. Immunol. 24, 1616&#x2013;1627 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda, A. et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 185, 2452&#x2013;2468 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35768006</ArticleId><ArticleId IdType="pmc">9189143</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman, B. et al. Muscle abnormalities worsen after post-exertional malaise in Long COVID. Nat. Commun. 15, 17 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38177128</ArticleId><ArticleId IdType="pmc">10766651</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of long COVID identified through immune profiling. Nature 623, 139&#x2013;148 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">10620090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler, C. et al. Persistent complement dysregulation with signs of thromboinflammation in active Long COVID. Science 383, eadg7942 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt, N. et al. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Nat. Cardiovas. Res. 2, 899&#x2013;916 (2023).</Citation></Reference><Reference><Citation>Guarnieri, J. W. et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 15, eabq1533 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari, M. et al. Prevalence of persistent SARS-CoV-2 in a large community surveillance study. Nature 626, 1094&#x2013;1101 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38383783</ArticleId><ArticleId IdType="pmc">10901734</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Plasma-based antigen persistence in the post-acute phase of COVID-19. Lancet Infect. Dis. 24, e345&#x2013;e347 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38604216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo, W. et al. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(24)00171-3 (2024).</Citation></Reference><Reference><Citation>Menezes, S. M. et al. Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition. Lancet Microbe https://doi.org/10.1016/S2666-5247(24)00055-7 (2024).</Citation></Reference><Reference><Citation>Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36517603</ArticleId><ArticleId IdType="pmc">9749650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-M&#xe1;rmol, R. et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Sci. Adv. 9, eadg2248 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37285437</ArticleId><ArticleId IdType="pmc">10246911</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, M. et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc. Natl Acad. Sci. USA 120, e2217232120 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37220275</ArticleId><ArticleId IdType="pmc">10235949</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje, M. &amp; Iwasaki, A. The neurobiology of long COVID. Neuron 110, 3484&#x2013;3496 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud, G. et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697&#x2013;707 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35255491</ArticleId><ArticleId IdType="pmc">9046077</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene, C. et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 27, 421&#x2013;432 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38388736</ArticleId><ArticleId IdType="pmc">10917679</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35216672</ArticleId><ArticleId IdType="pmc">8786632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, R. et al. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. EClinicalMedicine 56, 101783 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36643619</ArticleId><ArticleId IdType="pmc">9830133</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos Guedes de Sa, K. et al. A causal link between autoantibodies and neurological symptoms in long COVID. Preprint at medRxiv https://doi.org/10.1101/2024.06.18.24309100 (2024).</Citation></Reference><Reference><Citation>Chen, H. -J. et al. Transfer of IgG from Long COVID patients induces symptomology in mice. Preprint at bioRxiv https://doi.org/10.1101/2024.05.30.596590 (2024).</Citation></Reference><Reference><Citation>Turner, S. et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 34, 321&#x2013;344 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37080828</ArticleId><ArticleId IdType="pmc">10113134</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, A. C. et al. Serotonin reduction in post-acute sequelae of viral infection. Cell 186, 4851&#x2013;4867 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37848036</ArticleId><ArticleId IdType="pmc">11227373</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe0;, M. et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir. Med. 12, 225&#x2013;236 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinh, N. T. et al. Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. Lancet Respir. Med. 12, e33&#x2013;e34 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38614106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg-Morris, L. et al. COVID-19 vaccine effectiveness against post-COVID-19 condition among 589,722 individuals in Sweden: population based cohort study. Br. Med. J. 383, e076990 (2023).</Citation></Reference><Reference><Citation>Marra, A. R. et al. The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research. Antimicrob. Steward Healthc. Epidemiol. 3, e168 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38028898</ArticleId><ArticleId IdType="pmc">10644173</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison, C. J. et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat. Commun. 14, 6588 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37875536</ArticleId><ArticleId IdType="pmc">10598213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf, A. R. et al. COVID-19 mRNA vaccination reduces the occurrence of post-COVID conditions in U.S. children aged 5-17 years following omicron SARS-CoV-2 infection, July 2021-September 2022. Open Forum Infect. Dis. 10, ofad500.2466 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">10678185</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Bowe, B. &amp; Al-Aly, Z. Molnupiravir and risk of hospital admission or death in adults with COVID-19: emulation of a randomized target trial using electronic health records. Br. Med. J. 380, e072705 (2023).</Citation></Reference><Reference><Citation>Xie, Y., Bowe, B. &amp; Al-Aly, Z. Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records. Br. Med. J. 381, e073312 (2023).</Citation></Reference><Reference><Citation>Gottlieb, R. L. et al. Early remdesivir to prevent progression to severe COVID-19 in outpatients. N. Engl. J. Med. 386, 305&#x2013;315 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34937145</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Molnupiravir and risk of post-acute sequelae of COVID-19: cohort study. Br. Med. J. 381, e074572 (2023).</Citation></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern. Med. 183, 554&#x2013;564 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36951829</ArticleId><ArticleId IdType="pmc">10037200</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung, K. W., Baye, F., Baik, S. H. &amp; McDonald, C. J. Nirmatrelvir and molnupiravir and post&#x2013;COVID-19 condition in older patients. JAMA Intern. Med. 183, 1404&#x2013;1406 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37870856</ArticleId><ArticleId IdType="pmc">10594174</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond, J. et al. Nirmatrelvir for vaccinated or unvaccinated adult outpatients with COVID-19. N. Engl. J. Med. 390, 1186&#x2013;1195 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38598573</ArticleId><ArticleId IdType="pmc">11156287</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, X. et al. Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir. Nat. Commun. 14, 6463 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37833261</ArticleId><ArticleId IdType="pmc">10575921</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, B. et al. Oral simnotrelvir for adult patients with mild-to-moderate COVID-19. N. Engl. J. Med. 390, 230&#x2013;241 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38231624</ArticleId><ArticleId IdType="pmc">11156186</ArticleId></ArticleIdList></Reference><Reference><Citation>Antar, A. A. R. &amp; Peluso, M. J. CROI 2023: acute and post-acute COVID-19. Top. Antivir. Med 31, 493&#x2013;509 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37315513</ArticleId><ArticleId IdType="pmc">10266867</ArticleId></ArticleIdList></Reference><Reference><Citation>Yotsuyanagi, H. et al. Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial. Antiviral Res. 229, 105958 (2024).</Citation></Reference><Reference><Citation>Bramante, C. T. et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect. Dis. 23, 1119&#x2013;1129 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37302406</ArticleId><ArticleId IdType="pmc">11259948</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau, R. I. et al. A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 24, 256&#x2013;265 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng, L. N. et al. Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial. JAMA Intern. Med. 7, e242007 (2024).</Citation></Reference><Reference><Citation>Maley, J. H. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 14, 77&#x2013;95 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34902224</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteson, J. H. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 14, 855&#x2013;878 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35657351</ArticleId><ArticleId IdType="pmc">9347705</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera, J. E. et al. Response to letter to the editor regarding &#x2018;multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)&#x2019;. PM R. 13, 1439&#x2013;1440 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34617402</ArticleId><ArticleId IdType="pmc">8662053</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine, J. S. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 14, 96&#x2013;111 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34902226</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn, S. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 14, 1270&#x2013;1291 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj, S. R. et al. Canadian Cardiovascular Society Position Statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can. J. Cardiol. 36, 357&#x2013;372 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32145864</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Gonzalez, A. B. et al. Orthostatic tachycardia after COVID-19. Br. Med. J. 380, e073488 (2023).</Citation></Reference><Reference><Citation>Fedorowski, A. et al. Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden. Nat. Rev. Cardiol. 21, 379&#x2013;395 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38163814</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski, A. &amp; Sutton, R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 20, 281&#x2013;282 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36732397</ArticleId><ArticleId IdType="pmc">9893964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, A. L. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of mental health symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 15, 1588&#x2013;1604 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37937672</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed, E. et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 15, 640&#x2013;662 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36989078</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone, L. A. et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of postacute sequelae of SARS-CoV-2 infection (PASC) in children and adolescents. PM R. 14, 1241&#x2013;1269 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36169159</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T. &amp; Knight, M. Long COVID: a primer for family physicians. Am. Fam. Physician 102, 716&#x2013;717 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33320511</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Sivan, M., Delaney, B., Evans, R. &amp; Milne, R. Long COVID&#x2014;an update for primary care. Br. Med. J. 378, e072117 (2022).</Citation></Reference><Reference><Citation>Palacio, A., Bast, E., Klimas, N. &amp; Tamariz, L. Lessons learned in implementing a multidisciplinary long COVID clinic. Am. J. Med. https://doi.org/10.1016/j.amjmed.2024.05.020 (2024).</Citation></Reference><Reference><Citation>Greenhalgh, T., Darbyshire, J. L., Lee, C., Ladds, E. &amp; Ceolta-Smith, J. What is quality in long covid care? Lessons from a national quality improvement collaborative and multi-site ethnography. BMC Med. 22, 159 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38616276</ArticleId><ArticleId IdType="pmc">11017565</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunkersing, D. et al. What is current care for people with Long COVID in England? A qualitative interview study. BMJ Open 14, e080967 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38760030</ArticleId><ArticleId IdType="pmc">11107429</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman, M. et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir. Res. 8, e001041 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34764200</ArticleId><ArticleId IdType="pmc">8587466</ArticleId></ArticleIdList></Reference><Reference><Citation>Clutterbuck, D. et al. Barriers to healthcare access and experiences of stigma: Findings from a coproduced Long Covid case-finding study. Health Expect. 27, e14037 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38634418</ArticleId><ArticleId IdType="pmc">11024953</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen, A. et al. Understanding and tracking the impact of long COVID in the United Kingdom. Nat. Med. 28, 11&#x2013;15 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford, H. Long COVID is a double curse in low-income nations - here&#x2019;s why. Nature 625, 20&#x2013;22 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38172361</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou, R. et al. Long COVID definitions and models of care: a scoping review. Ann. Intern. Med. https://doi.org/10.7326/M24-0677 (2024).</Citation></Reference><Reference><Citation>Turk, F. et al. Pathways to care for Long COVID and for long-term conditions from patients&#x2019; and clinicians&#x2019; perspective. J. Evid. Based Med. 16, 435&#x2013;437 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38037477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon, J. et al. Impact of Long COVID on productivity and informal caregiving. Eur. J. Health. Econ. https://doi.org/10.1007/s10198-023-01653-z (2023).</Citation></Reference><Reference><Citation>O&#x2019;Mahony, L. et al. Impact of Long COVID on health and quality of life. HRB Open Res 5, 31 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36101871</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpman, M. et al. Employment and material hardship among adults with long COVID in December 2022. Urban Institute https://www.urban.org/sites/default/files/2023-07/Employment%20and%20Material%20Hardship%20among%20Adults%20with%20Long%20COVID%20in%20December%202022.pdf (July 2023).</Citation></Reference><Reference><Citation>McNabb, K. C. et al. &#x2018;It was almost like it&#x2019;s set up for people to fail&#x2019; A qualitative analysis of experiences and unmet supportive needs of people with Long COVID. BMC Public Health 23, 2131 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37904110</ArticleId><ArticleId IdType="pmc">10617090</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain, M. M. et al. Living with &#x2018;long COVID&#x2019;: a systematic review and meta-synthesis of qualitative evidence. PLoS ONE 18, e0281884 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36795701</ArticleId><ArticleId IdType="pmc">9934341</ArticleId></ArticleIdList></Reference><Reference><Citation>Au, L., Capotescu, C., Eyal, G. &amp; Finestone, G. Long COVID and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM Qual. Res. Health 2, 100167 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36092770</ArticleId><ArticleId IdType="pmc">9448633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27, 601&#x2013;615 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Agarwal, A., Alwan, N. &amp; Luyckx, V. A. Long COVID: long-term health outcomes and implications for policy and research. Nat. Rev. Nephrol. 19, 1&#x2013;2 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36319780</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz, G. M. et al. Understanding how post&#x2013;COVID-19 condition affects adults and health care systems. JAMA Health Forum 4, e231933 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37418268</ArticleId></ArticleIdList></Reference><Reference><Citation>Karpman, M., Zuckerman, S. &amp; Morriss, S. Health care access and affordability among US adults aged 18 to 64 years with self-reported post-COVID-19 condition. JAMA Netw. Open 6, e237455 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37036705</ArticleId><ArticleId IdType="pmc">10087049</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat, W. et al. Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet 402, 1115&#x2013;1117 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges, D. et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS ONE 16, e0254523 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34252157</ArticleId><ArticleId IdType="pmc">8274847</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Knight, M., A&#x2019;Court, C., Buxton, M. &amp; Husain, L. Management of post-acute COVID-19 in primary care. Br. Med. J. 370, m3026 (2020).</Citation></Reference><Reference><Citation>Bull-Otterson, L. et al. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly Rep. 71, 713&#x2013;717 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">9153460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett, C. E. et al. Risk for newly diagnosed diabetes &gt;30 days after SARS-CoV-2 infection among persons aged &lt;18 years&#x2014;United States, March 2020&#x2013;June 2021. MMWR Morb. Mortal. Wkly Rep. 71, 59&#x2013;65 (2022).</Citation></Reference><Reference><Citation>Zhang, T. et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 20, 444 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36380329</ArticleId><ArticleId IdType="pmc">9666960</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama, A. K. et al. Risk of cardiovascular disease after COVID-19 diagnosis among adults with and without diabetes. J. Am. Heart Assoc. 12, e029696 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37382101</ArticleId><ArticleId IdType="pmc">10356070</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W., Wang, C. -Y., Wang, S. -I. &amp; Wei, J. C. -C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine 53, 101619 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35971425</ArticleId><ArticleId IdType="pmc">9366236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. et al. Post-Covid syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. Br. Med. J. 372, n693 (2021).</Citation></Reference><Reference><Citation>Lawson, C. A. et al. Long COVID and cardiovascular disease: a prospective cohort study. Open Heart 11, e002662 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38802280</ArticleId><ArticleId IdType="pmc">11131117</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez, A. et al. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection. Open Heart 10, e002241 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis, A. et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. J. R. Soc. Med 116, 97&#x2013;112 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36787802</ArticleId><ArticleId IdType="pmc">10041626</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney, L. L. et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 55, 101762 (2023).</Citation></Reference><Reference><Citation>Al-Aly, Z. &amp; Cao, B. The enduring effect of the COVID-19 pandemic on diabetes. Lancet Diabetes Endocrinol. 12, 508&#x2013;510 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39054029</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhead, R. et al. Long COVID and financial outcomes: evidence from four longitudinal population surveys. J. Epidemiol. Community Health 78, 458&#x2013;465 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38508701</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler, D. M. The costs of long COVID. JAMA Health Forum 3, e221809 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler, D. The economic cost of long COVID: an update. Harvard Kennedy School https://scholar.harvard.edu/sites/scholar.harvard.edu/files/cutler/files/long_covid_update_7-22.pdf (2022).</Citation></Reference><Reference><Citation>Reuschke, D. &amp; Houston, D. The impact of Long COVID on the UK workforce. Appl. Econ. Lett. 30, 2510&#x2013;2514 (2023).</Citation></Reference><Reference><Citation>Gandjour, A. Long COVID: costs for the German economy and health care and pension system. BMC Health Serv. Res. 23, 641 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37316880</ArticleId><ArticleId IdType="pmc">10266873</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandri, E. et al. The economic burden of Long Covid in the UK. Cambridge Econometrics https://www.camecon.com/wp-content/uploads/2024/03/The-Economic-Burden-of-Long-Covid-in-the-UK_Cambridge-Econometrics_March2024.pdf (March 2024).</Citation></Reference><Reference><Citation>Fischer, K., Reade, J. J. &amp; Schmal, W. B. What cannot be cured must be endured: the long-lasting effect of a COVID-19 infection on workplace productivity. Labour Econ. 79, 102281 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36217320</ArticleId><ArticleId IdType="pmc">9535936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff Sagy, Y., Feldhamer, I., Brammli-Greenberg, S. &amp; Lavie, G. Estimating the economic burden of long-COVID: the additive cost of healthcare utilisation among COVID-19 recoverees in Israel. BMJ Glob. Health 8, e012588 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37463787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen, N., Pantelic, M., O&#x2019;Hara, M. E., Hastie, C. &amp; Alwan, N. A. Impact of long COVID-19 on work: a co-produced survey. Lancet 402, S98 (2023).</Citation></Reference><Reference><Citation>Perlis, R. H. et al. Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA Netw. Open 6, e2256152 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36790806</ArticleId><ArticleId IdType="pmc">9932847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. et al. Employment outcomes of people with Long Covid symptoms: community-based cohort study. Eur. J. Public Health 34, 489&#x2013;496 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38423541</ArticleId><ArticleId IdType="pmc">11161149</ArticleId></ArticleIdList></Reference><Reference><Citation>Packard, S. E. &amp; Susser, E. Association of long COVID with housing insecurity in the United States, 2022&#x2013;2023. SSM Popul. Health 25, 101586 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38222672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach, K. New data shows Long COVID is keeping as many as 4 million people out of work. Brookings https://www.brookings.edu/articles/new-data-shows-long-covid-is-keeping-as-many-as-4-million-people-out-of-work/ (24 August 2022).</Citation></Reference><Reference><Citation>Ham, D. Long-haulers and labor market outcomes. Federal Reserve Bank of Minneapolis https://www.minneapolisfed.org/research/institute-working-papers/long-haulers-and-labor-market-outcomes (7 July 2022).</Citation></Reference><Reference><Citation>Trades Union Congress. Workers&#x2019; experiences of Long Covid. A TUC report. TUC https://www.tuc.org.uk/research-analysis/reports/workers-experience-long-covid (27 March 2023).</Citation></Reference><Reference><Citation>Ramos, S. C., Maldonado, J. E., Vandeplas, A &amp; V&#xe1;nyol&#xf3;s, I. Long COVID: a tentative assessment of its impact on labour market participation and potential economic effects in the EU. In ECONOMIC BRIEF 077 (European Commission Directorate-General for Economic and Financial Affairs, 2024).</Citation></Reference><Reference><Citation>Gonzalez, A. E. &amp; Suzuki, E. The impacts of long COVID across OECD countries. OECD Health Working Papers 167 (OECD Publishing, 2024).</Citation></Reference><Reference><Citation>Baxa, M. An incomplete picture: understanding the burden of long COVID. The Economist Impact https://impact.economist.com/perspectives/sites/default/files/download/ei264_-_an_incomplete_picture_understanding_the_burden_of_long_covid_v8.pdf (29 April 2024).</Citation></Reference><Reference><Citation>Yuan, H. et al. Progress towards the Sustainable Development Goals has been slowed by indirect effects of the COVID-19 pandemic. Commun. Earth Environ. 4, 184 (2023).</Citation></Reference><Reference><Citation>Luyckx, V. A. et al. Sustainable Development Goals relevant to kidney health: an update on progress. Nat. Rev. Nephrol. 17, 15&#x2013;32 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33188362</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar, K. M. J. et al. Disparities in outcomes among COVID-19 patients in a large health care system in California. Health Aff. 39, 1253&#x2013;1262 (2020).</Citation></Reference><Reference><Citation>Mart&#xed;n-Blanco, C., Zamorano, M., Liz&#xe1;rraga, C. &amp; Molina-Moreno, V. The impact of COVID-19 on the Sustainable Development Goals: achievements and expectations. Int. J. Environ. Res. Public Health 19, 16266 (2022).</Citation></Reference><Reference><Citation>Shuai, C. et al. Quantifying the impacts of COVID-19 on Sustainable Development Goals using machine learning models. Fundam. Res. https://doi.org/10.1016/j.fmre.2022.06.016 (2022).</Citation></Reference><Reference><Citation>Luyckx, V. A. &amp; Al-Aly, Z. Impact of COVID-19 on the Sustainable Development Agenda and Global Kidney Health. J. Am. Soc. Nephrol. 34, 941&#x2013;943 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36918385</ArticleId><ArticleId IdType="pmc">10278800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameli, M., Shams Esfandabadi, Z., Sadeghi, S., Ranjbari, M. &amp; Zanetti, M. C. COVID-19 and Sustainable Development Goals (SDGs): scenario analysis through fuzzy cognitive map modeling. Gondwana Res. 114, 138&#x2013;155 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35132304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S., Anser, M. K., Yao-Ping Peng, M. &amp; Chen, C. Visualizing the sustainable development goals and natural resource utilization for green economic recovery after COVID-19 pandemic. Resour. Policy 80, 103182 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36530833</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, W. et al. Achieving the Sustainable Development Goals in the post-pandemic era. Humanit. Soc. Sci. Commun. 9, 258 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35967482</ArticleId><ArticleId IdType="pmc">9362700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukkahatai, N., Rodney, T., Ling, C., Daniel, B. &amp; Han, H. R. Long COVID in the context of social determinants of health. Front. Public Health 11, 1098443 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37056649</ArticleId><ArticleId IdType="pmc">10088562</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger, Z., Altiery, D. E. J. V., Assoumou, S. A. &amp; Greenhalgh, T. Long COVID and health inequities: the role of primary care. Milbank Q 99, 519&#x2013;541 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33783907</ArticleId><ArticleId IdType="pmc">8241274</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry, B. L., Aronson, B. &amp; Pescosolido, B. A. Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland. Proc. Natl Acad. Sci. USA 118, e2020685118 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33547252</ArticleId><ArticleId IdType="pmc">7923675</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoto, S. A. Long COVID and chronic pain: overlapping racial inequalities. Disabil. Soc. 38, 524&#x2013;529 (2023).</Citation></Reference><Reference><Citation>Al-Aly, Z. Prevention of long COVID: progress and challenges. Lancet Infect. Dis. 23, 776&#x2013;777 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37156258</ArticleId><ArticleId IdType="pmc">10162711</ArticleId></ArticleIdList></Reference><Reference><Citation>Au, L., Capotescu, C., Curi, A., Gon&#xe7;alves Leonel da Silva, R. &amp; Eyal, G. Long COVID requires a global response centred on equity and dialogue. Glob. Health Action 16, 2244757 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37581581</ArticleId><ArticleId IdType="pmc">10431739</ArticleId></ArticleIdList></Reference><Reference><Citation>McCorkell, L., Assaf, G, S., Davis, H, E., Wei, H. &amp; Akrami, A. Patient-led research collaborative: embedding patients in the Long COVID narrative. Pain Rep. 6, e913 (2021).</Citation></Reference><Reference><Citation>Alwan, N. A. The road to addressing Long Covid. Science 373, 491&#x2013;493 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel, J. &amp; Vogel, G. Vaccines may cause rare, Long Covid-like symptoms. Science 375, 364&#x2013;366 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35084966</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer, U. Animal model of long COVID? Nat. Rev. Microbiol. 20, 446 (2022).</Citation></Reference><Reference><Citation>Silva, J. et al. Sex differences in symptomatology and immune profiles of Long COVID. Preprint at medRxiv https://doi.org/10.1101/2024.02.29.24303568 (2024).</Citation></Reference><Reference><Citation>Lammi, V. et al. Genome-wide association study of Long COVID. Preprint at medRxiv https://doi.org/10.1101/2023.06.29.23292056 (2023).</Citation></Reference><Reference><Citation>Lee, Y. et al. EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Sci. Rep. 12, 11478 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35798818</ArticleId><ArticleId IdType="pmc">9261254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturkler, Z. &amp; Kalkan, R. A new perspective of COVID-19 infection: an epigenetics point of view. Glob. Med. Genet. 9, 4&#x2013;6 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35169776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, R. et al. SARS-CoV-2 restructures host chromatin architecture. Nat. Microbiol. 8, 679&#x2013;694 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36959507</ArticleId><ArticleId IdType="pmc">10116496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatmaitan, B. G., Chason, J. L. &amp; Lerner, A. M. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J. Exp. Med. 131, 1121&#x2013;1136 (1970).</Citation><ArticleIdList><ArticleId IdType="pubmed">4246139</ArticleId><ArticleId IdType="pmc">2138852</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rhijn-Brouwer, F. C. C. et al. Graded exercise therapy should not be recommended for patients with post-exertional malaise. Nat. Rev. Cardiol. 21, 430&#x2013;431 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38279047</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study. Lancet Infect. Dis. 24, 239&#x2013;255 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38104583</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinney, L. Pandemics disable people&#x2014;the history lesson that policymakers ignore. Nature 602, 383&#x2013;385 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35173335</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinney, L. Pale Rider: The Spanish Flu of 1918 and How it Changed the World (PublicAffairs, 2017).</Citation></Reference><Reference><Citation>Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein&#x2013;Barr virus associated with multiple sclerosis. Science 375, 296&#x2013;301 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano, G. B. Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to Long COVID. Med. Sci. Monit. 27, e931447 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33633106</ArticleId><ArticleId IdType="pmc">7924007</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahratian A., Lin, J. -M. S., Bertolli J. &amp; Unger E. R. Myalgic encephalomyelitis/chronic fatigue syndrome in adults: United States, 2021&#x2013;2022. NCHS Data Brief 488, 1&#x2013;6 (2023).</Citation></Reference><Reference><Citation>Komaroff, A. L. Advances in understanding the pathophysiology of chronic fatigue syndrome. J. Am. Med. Assoc. 322, 499&#x2013;500 (2019).</Citation></Reference><Reference><Citation>Paul, B. D., Lemle, M. D., Komaroff, A. L. &amp; Snyder, S. H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl Acad. Sci. USA 118, e2024358118 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34400495</ArticleId><ArticleId IdType="pmc">8403932</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner, S. et al. Understanding, diagnosing, and treating myalgic encephalomyelitis/chronic fatigue syndrome - state of the art: Report of the 2nd International Meeting at the Charite Fatigue Center. Autoimmun. Rev. 22, 103452 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37742748</ArticleId></ArticleIdList></Reference><Reference><Citation>Arron, H. E. et al. Myalgic encephalomyelitis/chronic fatigue syndrome: the biology of a neglected disease. Front. Immunol. 15, 1386607 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38887284</ArticleId><ArticleId IdType="pmc">11180809</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg, D. L. How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes. Semin. Arthritis Rheum. 67, 152455 (2024).</Citation></Reference><Reference><Citation>Arun, S., Storan, A. &amp; Myers, B. Mast cell activation syndrome and the link with long COVID. Br. J. Hosp. Med. 83, 1&#x2013;10 (2022).</Citation></Reference><Reference><Citation>Salvucci, F. et al. Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation. Front. Cardiovasc. Med. 10, 1202696 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37529714</ArticleId><ArticleId IdType="pmc">10388239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumantri, S. &amp; Rengganis, I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac. Allergy 13, 50&#x2013;53 (2023).</Citation></Reference><Reference><Citation>Weinstock, L. B. et al. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 112, 217&#x2013;226 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34563706</ArticleId><ArticleId IdType="pmc">8459548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda, K. R., Blakey, E. E., Huang, C. L. &amp; Jeevaratnam, K. Long COVID-19 and postural orthostatic tachycardia syndrome&#x2014;is dysautonomia to be blamed? Front. Cardiovasc. Med. 9, 860198 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35355961</ArticleId><ArticleId IdType="pmc">8959615</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer, J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve 65, E31&#x2013;E32 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35385125</ArticleId><ArticleId IdType="pmc">9088382</ArticleId></ArticleIdList></Reference><Reference><Citation>Margalit, I. &amp; Yahav, D. The potential role of vagus nerve dysfunction and dysautonomia in long COVID. Clin. Microbiol. Infect. 30, 423&#x2013;427 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38185275</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist, J. T. et al. Lung abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID. Radiology 305, 709&#x2013;717 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Hernandez, R. et al. Mapping microglia and astrocyte activation in vivo using diffusion MRI. Sci. Adv. 8, eabq2923 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35622913</ArticleId><ArticleId IdType="pmc">9140964</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob, L. et al. Conserved meningeal lymphatic drainage circuits in mice and humans. J. Exp. Med. 219, e20220035 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35776089</ArticleId><ArticleId IdType="pmc">9253621</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107;, M. et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 13, 5808 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37037833</ArticleId><ArticleId IdType="pmc">10086005</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner, S., Laubscher, G. J., Khan, M. A., Kell, D. B. &amp; Pretorius, E. Accelerating discovery: a novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model. Heliyon 9, e19605 (2023).</Citation></Reference><Reference><Citation>Peluso, M. J. et al. Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection. Sci. Transl. Med. 16, eadk3295 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38959327</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n, E. et al. Cellular and molecular biomarkers of long COVID: a scoping review. eBioMedicine 91, 104552 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37037165</ArticleId><ArticleId IdType="pmc">10082390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai, Y. J. et al. Biomarkers in long COVID-19: a systematic review. Front. Med. 10, 1085988 (2023).</Citation></Reference><Reference><Citation>Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479&#x2013;1495 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33171100</ArticleId><ArticleId IdType="pmc">7598382</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. et al. Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge. Cell Death Dis. 13, 235 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35288537</ArticleId><ArticleId IdType="pmc">8919172</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusu, E. C. et al. Towards understanding post-COVID-19 condition: a systematic meta-analysis of transcriptomic alterations with sex-specific insights. Comput. Biol. Med. 175, 108507 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38657468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, X. et al. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine 98, 104851 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37924708</ArticleId><ArticleId IdType="pmc">10660018</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosef, C. et al. Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function. J. Transl. Med. 21, 377 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37301958</ArticleId><ArticleId IdType="pmc">10257382</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, X., Wang, Y. &amp; Guo, T. Proteomics approaches to long COVID: status and outlooks. Life Med. 2, 3 (2023).</Citation></Reference><Reference><Citation>Saito, S. et al. Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome. Front. Immunol. 15, 1341843 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38304426</ArticleId><ArticleId IdType="pmc">10830702</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez, Y. et al. Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery. Front. Mol. Biosci. 10, 1100486 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36936993</ArticleId><ArticleId IdType="pmc">10022496</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. et al. The causal role of gut microbiota in susceptibility of Long COVID: a Mendelian randomization study. Front. Microbiol. 15, 1404673 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38873142</ArticleId><ArticleId IdType="pmc">11169722</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220&#x2013;232 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33428867</ArticleId><ArticleId IdType="pmc">7833295</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z. Long COVID and its cardiovascular implications: a call to action. Eur. Heart J. 44, 5001&#x2013;5003 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37949826</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. J. Am. Med. Assoc. 329, 1934&#x2013;1946 (2023).</Citation></Reference><Reference><Citation>Reese, J. T. et al. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. eBioMedicine 87, 104413 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat. Med. 29, 226&#x2013;235 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew, F. et al. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nat. Immunol. 25, 607&#x2013;621 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38589621</ArticleId><ArticleId IdType="pmc">11003868</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews, A. A., Danaei, G., Islam, N. &amp; Kurth, T. Target trial emulation: applying principles of randomised trials to observational studies. Br. Med. J. 378, e071108 (2022).</Citation></Reference><Reference><Citation>Hern&#xe1;n, M. A., Wang, W. &amp; Leaf, D. E. Target trial emulation: a framework for causal inference from observational data. J. Am. Med. Assoc. 328, 2446&#x2013;2447 (2022).</Citation></Reference><Reference><Citation>Xie, Y., Bowe, B., Maddukuri, G. &amp; Al-Aly, Z. Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza: cohort study. Br. Med. J. 371, m4677 (2020).</Citation></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in Fall-Winter 2022&#x2013;2023. J. Am. Med. Assoc. 329, 1697&#x2013;1699 (2023).</Citation></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly, Z. Mortality in patients hospitalized for COVID-19 vs influenza in Fall-Winter 2023&#x2013;2024. J. Am. Med. Assoc. 331, 1963&#x2013;1965 (2024).</Citation></Reference><Reference><Citation>The Lancet Infectious Diseases. Where are the long COVID trials? Lancet Infect. Dis. 23, 879 (2023).</Citation></Reference><Reference><Citation>Fairbank, R. Long COVID still has no cure&#x2014;so these patients are turning to research. Nature 628, 26&#x2013;28 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38565658</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan, N. A. Lessons from Long COVID: working with patients to design better research. Nat. Rev. Immunol. 22, 201&#x2013;202 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35169259</ArticleId><ArticleId IdType="pmc">8853146</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli, C. et al. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response. JCI Insight 6, e146701 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34784300</ArticleId><ArticleId IdType="pmc">8783674</ArticleId></ArticleIdList></Reference><Reference><Citation>Service, R. F. Bad news for Paxlovid? Resistance may be coming. Science 377, 138&#x2013;139 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35857562</ArticleId></ArticleIdList></Reference><Reference><Citation>Iketani, S. et al. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature 613, 558&#x2013;564 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36351451</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan, Y. et al. Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature 622, 376&#x2013;382 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37696289</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchholz, S., Di Meco, E., Balkowiec-Iskra, E. Z., Sepodes, B. &amp; Cavaleri, M. Generating clinical evidence for treatment and prevention options for long COVID. Nat. Med. https://doi.org/10.1038/s41591-024-03031-5 (2024).</Citation></Reference><Reference><Citation>Mohamed, M. O. &amp; Banerjee, A. Long COVID and cardiovascular disease: a learning health system approach. Nat. Rev. Cardiol. 19, 287&#x2013;288 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35332308</ArticleId><ArticleId IdType="pmc">8943785</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan, N. A. et al. Long Covid active case finding study protocol: a co-produced community-based pilot within the STIMULATE-ICP study (symptoms, trajectory, inequalities and management: understanding Long-COVID to address and transform existing integrated care pathways). PLoS ONE 18, e0284297 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37471432</ArticleId><ArticleId IdType="pmc">10358953</ArticleId></ArticleIdList></Reference><Reference><Citation>Black, R. E. et al. Health and development from preconception to 20 years of age and human capital. Lancet 399, 1730&#x2013;1740 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35489357</ArticleId><ArticleId IdType="pmc">9061873</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, S. L. et al. Social histories of public health misinformation and infodemics: case studies of four pandemics. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(24)00105-1 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00105-1</ArticleId><ArticleId IdType="pubmed">38701823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravenholt, R. T. &amp; Foege, W. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet 320, 860&#x2013;864 (1982).</Citation></Reference><Reference><Citation>Honigsbaum, M. &amp; Krishnan, L. Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers. Lancet 396, 1389&#x2013;1391 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33058777</ArticleId><ArticleId IdType="pmc">7550169</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehner, G. Howard Phillips, in a time of plague: memories of the &#x2018;Spanish&#x2019; flu epidemic of 1918 in South Africa. Soc. Hist. Med. 33, 343&#x2013;344 (2019).</Citation></Reference><Reference><Citation>Greenhalgh, T. et al. Masks and respirators for prevention of respiratory infections: a state of the science review. Clin. Microbiol Rev. 37, e0012423 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38775460</ArticleId></ArticleIdList></Reference><Reference><Citation>Etowa, J. et al. Understanding low vaccine uptake in the context of public health in high-income countries: a scoping review. Vaccines 12, 269 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38543903</ArticleId><ArticleId IdType="pmc">10975033</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Indoor airborne risk assessment in the context of SARS-CoV-2: description of airborne transmission mechanism and method to develop a new standardized model for risk assessment. https://iris.who.int/handle/10665/376346 (World Health Organization, 2024).</Citation></Reference><Reference><Citation>Morawska, L. et al. Mandating indoor air quality for public buildings. Science 383, 1418&#x2013;1420 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38547291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, D. Indoor air is full of flu and COVID viruses. Will countries clean it up? Nature 615, 206&#x2013;208 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36882616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunderberg, D. M. et al. Assessing residential PM<sub>2.5</sub> concentrations and infiltration factors with high spatiotemporal resolution using crowdsourced sensors. Proc. Natl Acad. Sci. USA 120, e2308832120 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38048461</ArticleId><ArticleId IdType="pmc">10723120</ArticleId></ArticleIdList></Reference><Reference><Citation>Grippo, A. et al. Indoor air pollution exposure and early childhood development in the Upstate KIDS Study. Environ. Res. 234, 116528 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37419197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K. K. et al. Adverse health effects associated with household air pollution: a systematic review, meta-analysis, and burden estimation study. Lancet Glob. Health 8, e1427&#x2013;e1434 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33069303</ArticleId><ArticleId IdType="pmc">7564377</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulimeno, M., Piscitelli, P., Colazzo, S., Colao, A. &amp; Miani, A. Indoor air quality at school and students&#x2019; performance: Recommendations of the UNESCO Chair on Health Education and Sustainable Development &amp; the Italian Society of Environmental Medicine (SIMA). Health Promot. Perspect. 10, 169&#x2013;174 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32802752</ArticleId><ArticleId IdType="pmc">7420173</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol, E. J. &amp; Iwasaki, A. Operation nasal vaccine&#x2014;lightning speed to counter COVID-19. Sci. Immunol. 7, eadd9947 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35862488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn, A. The Politics and History of AIDS Treatment in Brazil (Springer, 2008).</Citation></Reference><Reference><Citation>Grangeiro, A. et al. Forty years of the Brazilian response to HIV: reflections on the need for a programmatic shift and policy as a common good. Cad. Saude Publica 39, e00199423 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">10712913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheever, L. W., Rich, J. &amp; Adashi, E. Y. The Ryan White HIV/AIDS Program: thirty years of addressing health disparities. J. Health Care Poor Underserved 35, 726&#x2013;730 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38828591</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal, R. et al. The health equity implications of the Health Resources and Services Administration&#x2019;s Ryan White HIV/AIDS Program. AIDS 38, 1025&#x2013;1032 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38691049</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel-Larson, A. et al. Looking back to see forward: multidirectional learning between the US Ryan White HIV/AIDS Program and the US President&#x2019;s Emergency Plan for AIDS Relief. BMJ Glob. Health 8, e013953 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38395451</ArticleId><ArticleId IdType="pmc">10897372</ArticleId></ArticleIdList></Reference><Reference><Citation>de Beaumont Foundation. Poll: Physicians agree Long COVID is a problem but are unprepared to treat it. https://debeaumont.org/wp-content/uploads/2023/03/Long-COVID-Brief.pdf (2023).</Citation></Reference><Reference><Citation>National Center for Health Statistics Rapid Surveys System. Long COVID. https://www.cdc.gov/nchs/rss/round1/long-covid.html (accessed 1 July 2024).</Citation></Reference><Reference><Citation>Al-Aly, Z. Addressing Long COVID: Advancing Research and Improving Patient Care. US Senate Committee on Health, Education, Labor and Pensions https://www.help.senate.gov/download/al-aly-testimony?download=1 (18 January 2024).</Citation></Reference><Reference><Citation>Conroy, M. et al. The advantages of UK Biobank&#x2019;s open-access strategy for health research. J. Intern. Med. 286, 389&#x2013;397 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31283063</ArticleId><ArticleId IdType="pmc">6790705</ArticleId></ArticleIdList></Reference><Reference><Citation>Helzlsouer, K. J. &amp; Reedy, J. Data sharing for the public good. J. Natl Cancer Inst. 112, 867&#x2013;868 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31899487</ArticleId><ArticleId IdType="pmc">7492763</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. &amp; Diaz, J. V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102&#x2013;e107 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>US Centers for Disease Control. Long COVID or post-COVID conditions. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/ (accessed 1 July 2024).</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE https://www.nice.org.uk/guidance/ng188 (accessed 1 July 2024).</Citation></Reference><Reference><Citation>US Department of Health and Human Services, Office of the Assistant Secretary for Health. National Research Action Plan on Long COVID. covid.gov https://www.covid.gov/sites/default/files/documents/National-Research-Action-Plan-on-Long-COVID-08012022.pdf (August 2022).</Citation></Reference><Reference><Citation>Appel, K. S. et al. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection https://doi.org/10.1007/s15010-024-02226-9 (2024).</Citation></Reference><Reference><Citation>Alwan, N. A. &amp; Johnson, L. Defining long COVID: going back to the start. Med 2, 501&#x2013;504 (2021).</Citation></Reference><Reference><Citation>Sivan, M. &amp; Heightman, M. A new professional society for post-COVID condition and other post-viral conditions. Adv. Rehabil. Sci. Pract. 13, https://doi.org/10.1177/27536351241231351 (2024).</Citation></Reference><Reference><Citation>National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Global Health; Forum on Microbial Threats. Toward a Post-Pandemic World: Lessons from COVID-19 for Now and the Future: Proceedings of a Workshop (National Academies Press, 2022).</Citation></Reference><Reference><Citation>To respond to the threat of avian influenza, look back at lessons learned from COVID-19. Nat. Med. 30, 1507 (2024).</Citation></Reference><Reference><Citation>Sachs, J. D. et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet 400, 1224&#x2013;1280 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36115368</ArticleId><ArticleId IdType="pmc">9539542</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker, R. E. et al. Infectious disease in an era of global change. Nat. Rev. Microbiol. 20, 193&#x2013;205 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34646006</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira, T. &amp; Tegally, H. Will climate change amplify epidemics and give rise to pandemics? Science 381, eadk4500 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37616383</ArticleId></ArticleIdList></Reference><Reference><Citation>Marani, M., Katul, G. G., Pan, W. K. &amp; Parolari, A. J. Intensity and frequency of extreme novel epidemics. Proc. Natl Acad. Sci. USA 118, e2105482118 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34426498</ArticleId><ArticleId IdType="pmc">8536331</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson, C. J. et al. Climate change increases cross-species viral transmission risk. Nature 607, 555&#x2013;562 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35483403</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, G. &amp; Kawaoka, Y. Which virus will cause the next pandemic? Viruses 15, 199 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36680238</ArticleId><ArticleId IdType="pmc">9864092</ArticleId></ArticleIdList></Reference><Reference><Citation>Vastag, B. &amp; Mazur, B. Researchers warn covid-19 could cause debilitating long-term illness in some patients. The Washington Post https://www.washingtonpost.com/health/could-covid-19-cause-long-term-chronic-fatigue-and-illness-in-some-patients/2020/05/29/bcd5edb2-a02c-11ea-b5c9-570a91917d8d_story.html (30 May 2020).</Citation></Reference><Reference><Citation>Lowenstein, F. We need to talk about what coronavirus recoveries look like. The New York Times https://www.nytimes.com/2020/04/13/opinion/coronavirus-recovery.html (13 April 2020).</Citation></Reference><Reference><Citation>Callard, F. &amp; Perego, E. How and why patients made Long COVID. Soc. Sci. Med 268, 113426 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33199035</ArticleId><ArticleId IdType="pmc">7539940</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, E. COVID-19 can last for several months. The Atlantic https://www.theatlantic.com/health/archive/2020/06/covid-19-coronavirus-longterm-symptoms-months/612679/ (4 June 2020).</Citation></Reference><Reference><Citation>Nemer, M. Post-COVID-19 condition in Canada: what we know, what we don&#x2019;t know and a framework for action. Office of the Chief Science Advisor of Canada https://science.gc.ca/site/science/sites/default/files/attachments/2023/Post-Covid-Condition_Report-2022.pdf (2022).</Citation></Reference><Reference><Citation>Duddy, C. et al. Coronavirus: long COVID. House of Commons Library https://researchbriefings.files.parliament.uk/documents/CBP-9112/CBP-9112.pdf (29 February 2024).</Citation></Reference><Reference><Citation>European Commission. Network of expertise on Long COVID. https://health.ec.europa.eu/non-communicable-diseases/expert-group-public-health/network-expertise-long-covid_en (accessed 26 June 2024).</Citation></Reference><Reference><Citation>Parliament of Australia. Sick and tired: casting a long shadow. https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/LongandrepeatedCOVID/Report (April, 2023).</Citation></Reference><Reference><Citation>US Senate Committee on Health, Education, Labor, and Pensions. Chairman Bernie Sanders releases Long COVID moonshot legislative proposal. https://www.help.senate.gov/chair/newsroom/press/news-chairman-bernie-sanders-releases-long-covid-moonshot-legislative-proposal (9 April 2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>